These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1673616)

  • 21. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Faraggi D
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
    Andersson OK; Hedner T; Nyberg G
    Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isradipine in essential hypertension: the Belgian General Practitioners' Study.
    De Keyser P; Bouvé J; Clement D; Degraef R; Meurant JP; Rorive G; Van Thillo J
    Am J Med; 1989 Apr; 86(4A):103-9. PubMed ID: 2565687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hungarian Isradipine Study (HIS): long-term (3-year) effects on blood pressure and plasma lipids.
    Farsang C; Kapocsi J; Kiss I; Török E; Kerkovits G; Holló J; Jávor T
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):56S-60S. PubMed ID: 7946181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
    Winer N; Kirkendall WM; Canosa FL; Lewin AJ; McMahon FG; Carr AA; Cohen M
    J Clin Pharmacol; 1990 Nov; 30(11):1006-11. PubMed ID: 2147029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
    Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P; Meisner W; Hitzenberger G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure.
    Lacourcière Y; Poirier L; Dion D; Provencher P
    Am J Cardiol; 1990 Feb; 65(7):467-72. PubMed ID: 2137666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of isradipine on the maternal and fetal cardiovascular system in hypertensive disorders in pregnancy.
    Feiks A; Grünberger W; Meisner W
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):200S-202S. PubMed ID: 1827022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isradipine improves platelet function in hypertensives.
    Sinzinger H; Virgolini I; Rauscha F; Fitscha P; O'Grady J
    Eur J Clin Pharmacol; 1992; 42(1):43-6. PubMed ID: 1531796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter comparison of the safety and efficacy of isradipine and enalapril in the treatment of hypertension.
    Eisner GM; Johnson BF; McMahon FG; Rudd P; Sowers JR; Vargas R; Zemel M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):154S-157S. PubMed ID: 1827008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.
    Abarquez RF; Cabral EI; Namin EP; Calleja HB; Porciuncula CI; Divinagracia RA; Anastacio RV; Castillo RR
    Drugs; 1990; 40 Suppl 2():33-7. PubMed ID: 2150639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and long-term antihypertensive effect of bopindolol once daily or once weekly.
    Andersson O; Hedner T; Nyberg G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S74-6. PubMed ID: 2439826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.
    Widimský J; Lefflerová K; Dvorák I; Fedelesová V; Lupínek Z; Mayer O; Pinterová E
    Am J Cardiol; 1991 Apr; 67(10):36B-42B. PubMed ID: 1673580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effect of a new dihydropyridine calcium antagonist, PN 200-110 (isradipine), combined with pindolol.
    Hansson L; Dahlof B
    Am J Cardiol; 1987 Jan; 59(3):137B-140B. PubMed ID: 2949584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
    Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
    Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic study of short- and long-term isradipine treatment in patients with chronic ischemic congestive heart failure.
    McGrath BP; Newman R; Older P
    Am J Med; 1989 Apr; 86(4A):75-80. PubMed ID: 2523660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.